236 related articles for article (PubMed ID: 29650553)
1. Enduring epigenetic landmarks define the cancer microenvironment.
Pidsley R; Lawrence MG; Zotenko E; Niranjan B; Statham A; Song J; Chabanon RM; Qu W; Wang H; Richards M; Nair SS; Armstrong NJ; Nim HT; Papargiris M; Balanathan P; French H; Peters T; Norden S; Ryan A; Pedersen J; Kench J; Daly RJ; Horvath LG; Stricker P; Frydenberg M; Taylor RA; Stirzaker C; Risbridger GP; Clark SJ
Genome Res; 2018 May; 28(5):625-638. PubMed ID: 29650553
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
[TBL] [Abstract][Full Text] [Related]
3. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.
Shen Z; Qin X; Yan M; Li R; Chen G; Zhang J; Chen W
Oncotarget; 2017 Jan; 8(1):1290-1303. PubMed ID: 27901488
[TBL] [Abstract][Full Text] [Related]
6. Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma.
Halperin C; Hey J; Weichenhan D; Stein Y; Mayer S; Lutsik P; Plass C; Scherz-Shouval R
Cancer Res; 2022 Nov; 82(22):4139-4152. PubMed ID: 36287637
[TBL] [Abstract][Full Text] [Related]
7. Differential vitamin D 24-hydroxylase/CYP24A1 gene promoter methylation in endothelium from benign and malignant human prostate.
Deeb KK; Luo W; Karpf AR; Omilian AR; Bshara W; Tian L; Tangrea MA; Morrison CD; Johnson CS; Trump DL
Epigenetics; 2011 Aug; 6(8):994-1000. PubMed ID: 21725204
[TBL] [Abstract][Full Text] [Related]
8. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
[TBL] [Abstract][Full Text] [Related]
9. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.
Orr B; Riddick AC; Stewart GD; Anderson RA; Franco OE; Hayward SW; Thomson AA
Oncogene; 2012 Mar; 31(9):1130-42. PubMed ID: 21804603
[TBL] [Abstract][Full Text] [Related]
10. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation.
Doldi V; Callari M; Giannoni E; D'Aiuto F; Maffezzini M; Valdagni R; Chiarugi P; Gandellini P; Zaffaroni N
Oncotarget; 2015 Oct; 6(31):31441-60. PubMed ID: 26375444
[TBL] [Abstract][Full Text] [Related]
11. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer.
Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D
Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615
[TBL] [Abstract][Full Text] [Related]
12. Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study.
Cheng Y; Monteiro C; Matos A; You J; Fraga A; Pereira C; Catalán V; Rodríguez A; Gómez-Ambrosi J; Frühbeck G; Ribeiro R; Hu P
Clin Epigenetics; 2018; 10():54. PubMed ID: 29692867
[TBL] [Abstract][Full Text] [Related]
13. Immortalized Cancer-associated Fibroblasts Promote Prostate Cancer Carcinogenesis, Proliferation and Invasion.
Yu S; Jiang Y; Wan F; Wu J; Gao Z; Liu D
Anticancer Res; 2017 Aug; 37(8):4311-4318. PubMed ID: 28739723
[TBL] [Abstract][Full Text] [Related]
14. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
[TBL] [Abstract][Full Text] [Related]
17. The DNA methylation landscape of advanced prostate cancer.
Zhao SG; Chen WS; Li H; Foye A; Zhang M; Sjöström M; Aggarwal R; Playdle D; Liao A; Alumkal JJ; Das R; Chou J; Hua JT; Barnard TJ; Bailey AM; Chow ED; Perry MD; Dang HX; Yang R; Moussavi-Baygi R; Zhang L; Alshalalfa M; Laura Chang S; Houlahan KE; Shiah YJ; Beer TM; Thomas G; Chi KN; Gleave M; Zoubeidi A; Reiter RE; Rettig MB; Witte O; Yvonne Kim M; Fong L; Spratt DE; Morgan TM; Bose R; Huang FW; Li H; Chesner L; Shenoy T; Goodarzi H; Asangani IA; Sandhu S; Lang JM; Mahajan NP; Lara PN; Evans CP; Febbo P; Batzoglou S; Knudsen KE; He HH; Huang J; Zwart W; Costello JF; Luo J; Tomlins SA; Wyatt AW; Dehm SM; Ashworth A; Gilbert LA; Boutros PC; Farh K; Chinnaiyan AM; Maher CA; Small EJ; Quigley DA; Feng FY
Nat Genet; 2020 Aug; 52(8):778-789. PubMed ID: 32661416
[TBL] [Abstract][Full Text] [Related]
18. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3.
Maeda M; Takeshima H; Iida N; Hattori N; Yamashita S; Moro H; Yasukawa Y; Nishiyama K; Hashimoto T; Sekine S; Ishii G; Ochiai A; Fukagawa T; Katai H; Sakai Y; Ushijima T
Gut; 2020 Feb; 69(2):243-251. PubMed ID: 31085554
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
